Simplex Trading
GLMD icon

Simplex Trading’s Galmed Pharmaceuticals GLMD Stock Holding History

Simplex Trading’s Portfolio GLMD Stock Details GLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2
Closed -$6K – 10744
2021
Q4 		$6K Buy
+2
New +$7.22K ﹤0.01% 9405
2021
Q3 		– Hold
0
– – – 9639
2021
Q2 		– Hold
0
– – – 9816

Other funds holding GLMD

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $3.06B AUM 26.31% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Simplex Trading's GLMD Position: Q3 2022 in Review

Simplex Trading sold out of Galmed Pharmaceuticals (GLMD) in Q3 2022, closing a stake of 2 shares — an estimated $1K sold.

Simplex Trading first reported a position in GLMD in Q2 2021 and held it in 5 quarters. The position peaked at $39K in Q3 2021. 24 funds tracked by Wall St. Rank hold GLMD as of Q3 2022.

  • Simplex Trading reported no remaining Galmed Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Simplex Trading sold 2 Galmed Pharmaceuticals shares in Q3 2022, an estimated $1K.
  • Simplex Trading first reported a position in Galmed Pharmaceuticals in Q2 2021 and held it in 5 quarters.
  • Simplex Trading's Galmed Pharmaceuticals position peaked at $39K in Q3 2021.
  • 24 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q3 2022.

Based on Simplex Trading's 13F filing for Q3 2022, filed 4 Nov 2022.